4. Network effect estimates and ranking statistics for surgical or interventional PDA closure.

Ibuprofen Mean SUCRA, 0.88; median rank, 1 (95% CrI, 1‐2)
0.64 ( 0.17, 2.39)	Indomethacin Mean SUCRA, 0.61; median rank, 2 (95% CrI, 1‐2)
0.24 ( 0.06, 0.64)	0.40 ( 0.14, 0.66)	Placebo Mean SUCRA, 0.002; median rank, 3 (95% CrI, 3‐3)

The unlabeled data in the boxes are risk ratios (RRs) and 95% credible intervals (CrIs). A RR >1 suggests that the upper left treatment is associated with a higher risk of having the outcome of interest vs the corresponding lower right treatment and the opposite is true for an RR <1. SUCRA, surface under the cumulative ranking curve